Coming Soon
Women's Health is coming to REMEVi.
A dedicated women's health program — hormone replacement therapy, hair regrowth, and skin health — is in development. It will arrive with the same fully bilingual, licensed clinical care REMEVi built its GLP-1 program on. Our GLP-1 weight loss program is open to women today.
- In development
- Bilingual care · EN + ES
Women's Health & Telehealth
Care designed around women — in your language.
Women's health needs change across every stage of life, and hormonal transitions like perimenopause and menopause can affect sleep, mood, energy, skin, hair, and weight all at once. Too often, these concerns are treated in isolation — or dismissed entirely. Telehealth makes it possible to address them together: a confidential evaluation, a licensed provider's review, and treatment adjusted over time, all without rearranging your week around appointments.
For Spanish-speaking women, quality care in their own language is harder still to find. Most telehealth platforms operate in English only. REMEVi was built to close that gap. When the women's health program launches, every step — the intake, the clinical evaluation summary, medication instructions, and a dedicated care coordinator — will be available in fluent Spanish, not a machine translation.
That program is still in development. We chose to do one thing exceptionally well first: bilingual GLP-1 weight loss. Because weight and hormonal health are closely linked, metabolic care is a natural foundation for the broader women's health program to come. If weight is part of your picture, you do not have to wait — REMEVi's GLP-1 program is open to women in all 50 states plus DC today.
What's Coming
What REMEVi Women's Health will cover.
A look at the areas the program is being built to support — with the bilingual, licensed clinical care REMEVi is known for.
Hormone Replacement Therapy
Perimenopause and menopause bring hot flashes, sleep disruption, mood changes, and more. Bioidentical HRT — estrogen, progesterone, and where appropriate testosterone — can ease these symptoms when prescribed and monitored by a licensed provider with regular lab review.
Hair Regrowth
Female hair loss is common and treatable, and it responds best to protocols designed specifically for women. Minoxidil, spironolactone, and select combination formulas are tailored by a licensed provider to the type and stage of hair loss.
Skin Health
Prescription-strength skincare addresses acne, hyperpigmentation, and signs of aging with clinically studied ingredients such as tretinoin and azelaic acid — adjusted over time by a licensed provider rather than guessed at off the shelf.
Weight & Metabolic Health
Weight and hormones are deeply connected, and hormonal transitions often make weight harder to manage. This is why metabolic health is a natural starting point — and why REMEVi’s GLP-1 weight loss program is available to women today, ahead of the broader women’s health launch.
Informational only. The women's health program is not yet available for enrollment. Compounded and prescription medications require evaluation by a licensed provider; individual results vary.
FAQ
Women's health questions answered
REMEVi is preparing to add a dedicated women’s health program — covering hormone replacement therapy, hair regrowth, and skin health — in the months ahead. We are focused first on delivering an exceptional bilingual GLP-1 weight loss experience, and will expand into women’s health once that foundation is firmly established. This page will be updated the moment enrollment opens.
HRT replaces hormones — typically estrogen and progesterone, and sometimes testosterone — that decline during perimenopause and menopause. Bioidentical formulations are chemically identical to the hormones the body produces naturally. When prescribed and monitored by a licensed provider, HRT can ease hot flashes, sleep disruption, mood changes, and other symptoms of hormonal transition.
Female pattern hair loss (androgenetic alopecia) responds to different protocols than male hair loss. Evidence-based options include minoxidil, spironolactone, and — in select cases — finasteride, often used in oral or topical combination formulas. A licensed provider selects the approach based on the type and stage of hair loss and on overall health history.
Prescription skincare addresses concerns such as acne, hyperpigmentation, and signs of aging with clinically studied ingredients like tretinoin and azelaic acid. Because the right strength and combination depend on skin type and history, these treatments are prescribed and adjusted by a licensed provider rather than bought off the shelf.
Yes. Fully bilingual English and Spanish care is core to everything REMEVi builds. When the women’s health program launches, the intake, the clinical evaluation, medication instructions, and your care coordinator will all be available in Spanish — exactly as they are for the REMEVi GLP-1 weight loss program today.
REMEVi’s GLP-1 weight loss program is open today. It pairs compounded semaglutide or tirzepatide with licensed US providers, included care coaching, and bilingual support in all 50 states plus DC. Weight and metabolic health are closely tied to hormonal health, so many women begin here ahead of the broader women’s health launch.
Available Now
Start with GLP-1 weight loss.
Compounded semaglutide or tirzepatide, licensed US providers, included care coaching — bilingual, in all 50 states plus DC.
Explore the GLP-1 Program